Multiple bacterial and skin cellular components

The term Multiple bacterial and skin cellular components refers to the diverse array of biological structures and pathways targeted by pleiotropic topical agents, most notably azelaic acid. In pathogenic bacteria such as Cutibacterium acnes and Staphylococcus epidermidis, these components include the machinery for protein synthesis, which is inhibited to reduce microbial growth and the subsequent production of inflammatory free fatty acids (StatPearls, 2023). In human skin cells, the targets include the enzyme tyrosinase, which is inhibited to manage hyperpigmentation, and various proteins involved in the proliferation and differentiation of keratinocytes (PubChem, CID 2266). The anti-inflammatory effects associated with these targets are mediated through the reduction of reactive oxygen species (ROS) and the downregulation of pro-inflammatory cytokines (PubMed, PMID 25345334). Because this designation encompasses a variety of distinct molecular entities rather than a single receptor or enzyme, it represents a polypharmacological profile rather than a specific therapeutic target. This broad activity is clinically utilized to treat complex dermatological conditions like acne vulgaris and rosacea by simultaneously addressing infection, inflammation, and abnormal keratinization.

Other names

Bacterial and host cell componentsAzelaic acid targetsMicrobial and keratinocyte targets

Inhibition of microbial protein synthesis, reduction of follicular free fatty acids, and modulation of keratinocyte proliferation and tyrosinase activity.